Tocotrienols inhibited growth and induced apoptosis in human HeLa cells through the cell cycle signaling pathway

Shu-Jing Wu1, Lean-Teik Ng

  • 1Chia-Nan University of Pharmacy and Science, Tainan, Taiwan.

Abstract

Insights

Palm oil tocotrienols, specifically alpha- and gamma-tocotrienols, show potent anticancer effects against human cervical cancer cells. These compounds induce cell death and apoptosis by influencing key cell cycle proteins and IL-6 expression.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Palm oil tocotrienols exhibit diverse bioactivities, including anticancer properties.
  • Human cervical carcinoma (HeLa) cells are a model for studying cancer proliferation.

Purpose of the Study:

  • To investigate the antiproliferative effects of alpha-, gamma-, and delta-tocotrienols (alphaT3, gammaT3, deltaT3) and alpha-tocopherol (alphaT) on HeLa cells.
  • To elucidate the underlying mechanisms of action on the cell cycle signaling pathway.

Main Methods:

  • Cell proliferation assays to determine IC50 values.
  • Flow cytometry to assess cell cycle distribution and apoptosis.
  • Western blot analysis to evaluate protein expression related to cell cycle regulation and cytokine signaling.

Main Results:

  • Alpha- and gamma-tocotrienols demonstrated significantly higher potency in inhibiting HeLa cell proliferation compared to delta-tocotrienol and alpha-tocopherol.
  • Both alphaT3 and gammaT3 induced dose- and time-dependent cell death, characterized by G2/M cell cycle arrest and apoptosis.
  • AlphaT3 downregulated cyclin D3, p16, and CDK6, while gammaT3's effects on these proteins were not observed. Both enhanced IL-6 expression.

Conclusions:

  • Alpha- and gamma-tocotrienols are effective inhibitors of human cervical carcinoma cell proliferation.
  • Their antiproliferative mechanism involves cell cycle arrest, apoptosis induction, modulation of specific cell cycle proteins (cyclin D3, p16, CDK6), and IL-6 upregulation.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...